Home > Insider Trading > Filing (0001104659-24-128026)

Filing Details

Accession Number:: 0001104659-24-128026
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-12-12 16:15:40
Reporting Period:: 2024-12-10

Accepted Time:: 2024-12-12 16:15:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1554859	Semler Scientific Inc.	SMLR	Electromedical & Electrotherapeutic Apparatus (3845)	261367393

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1594342	Douglas Murphy-Chutorian	C/O Semler Scientific, Inc. 2340-2348 Walsh Avenue, Suite 2344 Santa Clara CA 95051	Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-12-10	140,083	$3.44	140,083	No	4	M	Direct
Common Stock	Disposition	2024-12-10	50,794	$59.74	89,289	No	4	S	Direct
Common Stock	Disposition	2024-12-10	12,790	$60.36	76,499	No	4	S	Direct
Common Stock	Disposition	2024-12-10	10,545	$61.45	65,954	No	4	S	Direct
Common Stock	Disposition	2024-12-10	871	$62.29	65,083	No	4	S	Direct
Common Stock	Acquisiton	2024-12-11	14,917	$3.44	80,000	No	4	M	Direct
Common Stock	Disposition	2024-12-11	891	$59.08	79,109	No	4	S	Direct
Common Stock	Disposition	2024-12-11	2,294	$60.29	76,815	No	4	S	Direct
Common Stock	Disposition	2024-12-11	2,315	$61.57	74,500	No	4	S	Direct
Common Stock	Disposition	2024-12-11	2,489	$62.35	72,011	No	4	S	Direct
Common Stock	Disposition	2024-12-11	500	$61.13	71,511	No	4	S	Direct
Common Stock	Disposition	2024-12-11	5,811	$62.28	65,700	No	4	S	Direct
Common Stock	Disposition	2024-12-11	9,254	$62.97	56,446	No	4	S	Direct
Common Stock	Disposition	2024-12-11	1,446	$63.80	55,000	No	4	S	Direct
Common Stock	Disposition	2024-12-12	55,000	$0.00	0	No	4	G	Direct
Common Stock	Acquisiton	2024-12-12	55,000	$0.00	155,313	No	4	G	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	G	Direct
No	4	G	Indirect	See Footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock option (right to buy)	Disposition	2024-12-10	140,083	$0.00	140,083	$3.44
Common Stock	Stock option (right to buy)	Disposition	2024-12-11	14,917	$0.00	14,917	$3.44

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
14,917		2025-07-20	No	4	M	Direct
0		2025-07-20	No	4	M	Direct

Footnotes

The shares were sold by the reporting person to cover the exercise price and withholding taxes.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.01 to $60.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding, the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.01 to $61.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding, the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.03 to $62.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding, the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.09 to $62.52, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding, the number of shares sold at each separate price within the range set forth in footnote (5) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.76 to $59.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding, the number of shares sold at each separate price within the range set forth in footnote (6) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.91 to $60.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding, the number of shares sold at each separate price within the range set forth in footnote (7) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.00 to $61.94, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding, the number of shares sold at each separate price within the range set forth in footnote (8) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding, the number of shares sold at each separate price within the range set forth in footnote (9) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.54 to $61.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding, the number of shares sold at each separate price within the range set forth in footnote (10) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.55 to $62.54, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding, the number of shares sold at each separate price within the range set forth in footnote (11) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.55 to $63.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding, the number of shares sold at each separate price within the range set forth in footnote (12) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.56 to $64.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding, the number of shares sold at each separate price within the range set forth in footnote (13) to this Form 4.
Shares are held in a family trust over which Dr. Murphy-Chutorian is co-Trustee with his spouse, and with whom he shares voting and investment power over such securities.
The shares underlying the option are fully vested and immediately exercisable.